Organogenesis Holdings Inc.
ORGOCIK 0001661181 · Pharmaceutical Preparations · Nasdaq
- Avista Healthcare Public Acquisition Corp. (until 2018-12-10)
Revenue (TTM)
$375.79M
+17.0% YoY
Q1 Apr 2026
Net Income (TTM)
−$59.82M
+4,201.0% YoY
Q1 Apr 2026
EPS Diluted (TTM)
−$0.60
+1,600.0% YoY
Q1 Apr 2026
Gross Margin
88.8%
Q1 Apr 2026
Operating Margin
-23.3%
Q1 Apr 2026
Net Margin
-15.9%
Q1 Apr 2026
Free Cash Flow (TTM)
−$30.6M
Q1 Apr 2026
Cash
$91.38M
Q1 Apr 2026
Total Debt
$49.63M
Q1 Apr 2026
Shares Outstanding
128.67M sh
Q1 Apr 2026